Blue Horseshoe Stocks

Blue Horseshoe Stocks: ISR, Bottom Plays & More

IsoRay, Inc. ISR

We first began tracking ISR back in early October as a potential bottom play, and just a few sessions subsequent to our first mention, we would witness a low of 1.22 (10/16).

It took just a couple of weeks for us to ride ISR to a 66% gain as it ran to a high of 2.03 at the end of October. It consolidated down from that level, and for the past month or so the stock has been trading channel between 1.50-1.70.

ISR is catching our attention once again this morning, as we picked up on a new update over the press wire regarding the company’s Cesium-131 low-dose radiation therapy for brain cancer sufferers (Learn More About Cesium-131).

The Barrow Neurological Institute conducted studies with 27 patients with several variations of brain cancer, and the company is reporting that there was no recurrence of the disease on the treated sites in 26 out of the 27 candidates, where other treatments had failed. >> Read PR

We’re going to be interested to see how the stock picks up trading following the holiday week, especially with such an encouraging piece of news out in the premarket. So far, the ISR has gone as high as 2.08 in preliminary trading this morning. We could be looking at a dip-and-scenario once the session commences; to remain interested we’ll want to see support hold at a minimum of 1.89 as that would mark a 50% retrace from the current premarket range.

Potential Bottom Plays

AEterna Zentaris, Inc. AEZS absolutely fell off a cliff back in early November, following FDA denial of a New Drug Application AEZS had submitted. The stock has spent the intervening time bottoming out, and it is now trading at all-time lows. This is exactly the sort of situation that sends us into “vulture-mode”, where we’re on the lookout for any signs of recovery after a stock has been hammered down.

Frontline, Ltd. FRO is a stock that is in the process of coming off of a recent bottom, and is showing signs of life here in today’s premarket, currently trading in the mid-1.30’s.

Extended Watchlist:
JNUG, GRPN, AG, ONNN

Blue Horseshoe Stocks: TASR & Extended Watchlist

TASER International, Inc. TASR

On Wednesday, we indicated our interest in TASR via our extended watchlist, after noticing an extremely topical PR hitting the wires that morning. For those of you who might not have made the connection, TASER refers to the popular brand of non-lethal electric weapons. The company does in fact make a range of other “public safety” products as well, including body-worn video cameras.

–

During a time when more and more people are calling for heightened law enforcement accountability, one apparent solution that seems to be gaining traction among citizens as well as civil servants is outfitting police with body cameras to continuously record their on-duty activity. On Wednesday, TASR announced that one department has made the move to full implementation with a large order (see PR below).

–

We want to continue to monitor the stock, as it hit new 52-week highs on Wednesday, and is gapping up in premarket trading today. It will be interesting to follow this play, especially if more and more agencies make the move to body cameras, as TASER is already a trusted name in the field, and could fill a lot of that demand.
SEATTLE, WA–(Marketwired – Nov 26, 2014) – TASER International (NASDAQ: TASR) today announced the purchase of 623 AXON body-worn video cameras and a five-year subscription to EVIDENCE.com by the Winston-Salem Police Department. This order was received in the fourth quarter of 2014 and is expected to ship in the fourth quarter of 2014. >> FULL PR

–

Side Note – TASR Options

Given the current scenario with the chart in blue sky territory, we’ll be on the lookout for a dip-and-rip setup, and in that event we’ll be focusing on the 12/20 $21 & $22 Calls for possible intraday flip opportunities during today’s short session.

Extended Watchlist:
VRNG, REDG (News), AVIX

Blue Horseshoe Stocks: LAKE Recap & More

Lakeland Industries, Inc. LAKE

Yesterday’s report turned up another premium opportunity for us to take advantage of a big intraday move. LAKE produced the largest percentage gain on the NASDAQ, starting out in the morning at a low of 10.32, and pressing upward all day long, hitting its high of 13.68 just prior to the closing bell. That equates to a strong 32% increase, and it came on more than twice the 3-month average volume.

LAKE is probably going to be a stock that we’ll want to monitor into the new year, following the recent revelation that the company would be releasing its Q3 financials on December 10th, which are expected to include increased sales to the tune of +15% We’ve been made aware that those numbers will not reflect international sales or impact from Ebola-related orders which are expected to be realized in fiscal Q4 2015 (period ending 01/31/15) >> Read PR

Options-Trading Side Note:

We want to give ourselves a pat on the back for accurately determining how to approach PBR this week. Just to give a quick rundown; we outlined the PBR January 17th $10 and $11 Calls in Monday’s report. We watched as they dipped back and gave us a good chance for a discounted entry, and in yesterday’s premarket report, stated that we’d attempt to reap our profits on the gap-up that was in progress.

From the lows we observed Monday, ($10: 1.16, $11: .67) we were able to achieve significant gains at yesterday’s early highs. The $10 Calls ran as high as 1.57 (+35%) and the $11 Calls saw the 1.00-mark (+49%).

There’s still plenty of time before these contracts expire, so there’s a good chance that we’ll be able to realize further opportunities down the road from the PBR 01/17 $10 and $11 Calls.

Let us take this opportunity to wish all of our members a safe and happy holiday, and we’ll see everyone for a half-session on Friday.

Extended Watchlist:
TASR, GPRO, CZZ, FCEL, JCP

Blue Horseshoe Stocks: Update on AEMD & More

Aethlon Medical, Inc. AEMD

Yesterday’s standout play was AEMD, a stock that we’ve been tracking since October 14th. Following that initial alert, we observed a low of .20 in AEMD, and after trading sideways for the remainder of last month, the stock has been gaining ground steadily over the past few weeks.

We re-flagged it in yesterday’s extended watchlist and witnessed a 27% intraday run from .562-.717 on approximately 10X the 3-month average trading volume. At its high mark of .717, AEMD was showing us an increase of 258% over the lows we observed barely a month ago.

The event that prompted us to originally begin following AEMD was during the height of the Ebola scare, when the company announced that its “Hemopurifier” blood-cleansing system was to be used to treat an Ebola patient overseas. This morning, we ‘re getting word that the patient (who was experiencing multiple organ failure at the time the treatment was administered) has now been discharged from the hospital. >>> FULL PR

It will be interesting to see the effect this news has on AEMD as we approach the holiday hiatus, which shortens this to a 3½ day trading week.

Petroleo Brasiliero S.A. (Petrobras) PBR -Options

PBR is gapping up again this morning, in the wake of yesterday’s announcement that its ‘Cidade de Ilhabela’ offshore oil platform had been brought online. (Read our comments on the company’s situation in yesterday’s report if you missed it)

Anyone who caught yesterday’s morning report will recall our options-trading targets; we were considering the Jan 17th $10 and $11 Calls. The gap-and-fade that followed provided us a good opportunity to snap up some discounted contracts, and we’ll be looking to lock in some profits on the gap-up we’re seeing this morning.

SinoCoking Coal and Coke Chemical Industries, Inc. SCOK

Another play that we’ve been monitoring for some time is SCOK, which we’ll want to watch closely today on the heels of a notable PR released this morning. According to SCOK, the syngas plant that it recently opened in China is now operating at 100% capacity and pulling more than $80K worth of syngas from the Earth per day.

We actually began tracking SCOK the morning it announced its intent to open the facility, (it ran hard that day from 3.35-9.37, +180%) so this morning’s PR regarding the plant acheiving full operational status brings us full circle with SCOK.

PINGDINGSHAN, China, Nov. 25, 2014 (GLOBE NEWSWIRE) — SinoCoking Coal and Coke Chemical Industries, Inc. (SCOK), a producer of clean energy products located in Henan Province, today announced that its above ground facility for the conversion of carbon dioxide into clean-burning syngas has achieved its initial production target of 25,000 cubic meters per hour and is currently transporting syngas to three customers and agents in and around its facility in Pingdingshan.

Based on the current price of $0.139 per cubic meter for syngas, the gross revenue generated per day by the aboveground facility is approximately $83,280. Gross profit margin is expected to be between 45% and 50%. >> FULL PR

Extended Watchlist:
ISNS, LAKE, CAMT, DRWI, LIVE

Blue Horseshoe Stocks: Commenting on PBR & More

Petroleo Brasiliero S.A. (Petrobras) PBR

Amid allegations of money-laundering and bribery which extend high up into the Brazilian government (including former PBR board member and President Dilma Rousseff) the sixth-largest energy company in the world, and a point of focus for us all year, could be forced to write down billions in assets and reduce dividends. The company’s Q3 financials are being delayed indefinitely as a result.

The long-term implications of such a scandal are too vast and varied for us to make even a brief assessment accurately. What we can do is stay extra tuned to the PBR newsfeed to stay as up-to-date as possible on current events and adhere to our technicals, because we can still see potential on the chart.

On Tuesday, PBR hit its all-time low of 8.80. but has since made higher lows and higher highs over the proceeding sessions. After we tagged it on Friday morning, there was a 9% intraday move from 10.08 to $11, and this morning the premarket high is 11.51, which will act as immediate resistance as the session kicks off. We’ll want to see support hold at roughly 10.85, but if PBR can break past this morning’s high to confirm its continued uptrend, the next thing we’d be looking for is the filling of a gap on the chart from approximately $12-12.50.

As far as options go, we’re presently looking at the Jan 17th $10 and $11 Calls, provided the current trend continues.

Prosensa Holdings (N.V.) RNA

RNA is a stock that we tracking periodically this spring and summer, and we just wanted to comment quickly on the buyout offer the company announced this morning. In a $680M deal, Prosensa will receive around $17.75/share from buyer BioMarin Pharmaceutical.

Following an alert we put out on RNA back in May, the stock was trading at a low of 7.96; this morning’s premarket high of $19 means we’ve seen more than a 130% move in this play over a span of about 5 months.

Extended Watchlist:
MOLG, GERN, CIMT, SYN, AEMD, MY